Abstract: A force transducer is disclosed, which is arranged in such a way that, when a force is applied to the force transducer, two output signals from the force transducer are generated, which output signals are representative of the force components in a first plane and in a second plane perpendicular to the first plane, respectively, whereas force components in a third plane perpendicular to the first plane and the second plane do not affect the output signals from the force transducer. Furthermore, a measuring device is disclosed, comprising a handle comprising such a force transducer and a base unit, to which the handle is attached. Even further, a system for measuring muscle stiffness is disclosed, comprising a measuring unit and a processing unit, the measuring unit comprising such a measuring device.

Abstract: A force transducer is disclosed, which is arranged in such a way that, when a force is applied to the force transducer, two output signals from the force transducer are generated, which output signals are representative of the force components in a first plane and in a second plane perpendicular to the first plane, respectively, whereas force components in a third plane perpendicular to the first plane and the second plane do not affect the output signals from the force transducer. Furthermore, a measuring device is disclosed, comprising a handle comprising such a force transducer and a base unit, to which the handle is attached. Even further, a system for measuring muscle stiffness is disclosed, comprising a measuring unit and a processing unit, the measuring unit comprising such a measuring device.

Abstract: A system, an apparatus, and a method for measuring muscle stiffness in a predetermined joint of an individual are provided. The system and apparatus comprises a measuring unit and a processing unit. The measuring unit is configured to be applied to a body segment of the predetermined joint. The processing unit is configured to: receive a plurality of data sets from the at least one measurement device, analyze the plurality of data sets for one or more indications of an elicited stretch reflex, and calculate a muscle stiffness score. The muscle stiffness score is based on at least a difference between a first stiffness and a second stiffness. The first stiffness is determined from the first subset, and the second stiffness is determined from the second subset.

Abstract: Apolipoprotein M forms a complex with sphingosine-1-phosphate (S1P) and is the carrier of S1P in high density lipoprotein particles and mediates its endothelial protective effect. Increasing the concentration of the apoM/S1P complex by administering it, either alone or in HDL particles, can prevent or treat diseases caused by endothelial cell injury, including inflammatory diseases, sepsis, atherosclerosis and acute lung injury, ischemic heart disease, stroke, vital organ failure after ischemic stress.

Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Abstract: Appointment information for a user may be entered at a computer. A first signal may be sent from the computer, via a network, to a server remote from the computer, the content of the first signal including for example data related to the appointment information. Sending the first signal may be triggered by completion of the entering appointment information for the user. The content of the first signal may be processed at the server according to the appointment information, and a message may be sent from the server to the user relating to the appointment. A response to the message may be received from the user.

Abstract: A hearing aid with anti feed back system, the hearing aid including a signal path from at least one input transducer to an output transducer, a signal processing unit, acoustic environment detection capability, and a parameter generator that generates input to the setting of signal processing parameters to be used in the signal processing unit based on either manual input or from the results of acoustic environment detection, and an alert signal generator that generates an alert signal to the anti feed back system whenever one or more preselected input to the generation of signal processing parameters undergoes changes.

Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Abstract: A method for the preparation of a package comprising a packing means holding a medical device element of a substrate polymer, said substrate polymer having on at least a part of the surface thereof a hydrophilic coating, wherein the hydrophilic coating has been applied to the surface of said substrate polymer in the form of a solution of a hydrophilic polymer selected from the groups consisting of polyvinylpyrrolidone and polyethylene oxide in a vehicle comprising an optionally substituted 1,3-dioxolane compound, followed by evaporation of at least part of the vehicle and arranging said medical device element having the coating of the non-cross-linked hydrophilic polymer within a packing means, and sealing said packing means.

Abstract: The present invention provides an assembly for the preparation of a medical device having a porous coating comprising hydrogen peroxide. Particularly interesting medical devices are catheters (such as urinary catheters), endoscopes, laryngoscopes, tubes for feeding, tubes for drainage, guide wires, condoms, urisheaths, barrier coatings e.g. for gloves, stents and other implants, extra corporeal blood conduits, membranes e.g. for dialysis, blood filters, devices for circulatory assistance, dressings for wound care, and ostomy bags. The coating is in particular a hydrophilic coating formed from cross-linked polyvinylpyrrolidone. In one embodiment, the assembly holds a dry catheter element in one compartment of a package and an aqueous hydrogen peroxide solution in another compartment. The solution may also comprise stabilizers, e.g. chelators, and osmolality increasing agents.

Abstract: The present invention provides a method for the preparation of a cross-linked hydrophilic coating of a hydrophilic polymer on a substrate polymer surface of a medical device, involving the use of a polymer solution comprising 1-20% by weight of a hydrophilic polymer, 0-5% by weight of additive(s), and the balance of a vehicle with plasticizing effect on the hydrophilic polymer, wherein the vehicle comprises at least one plasticizer having a solubility in water of at least 6 g/L, a boiling point above 210° C. at 760 mmHg, and Hansen ?H parameter of less than 20. Furthermore, the invention provides a medical device, e.g. a catheter or guide wire, provided with such a hydrophilic coating. The invention also provides the use of specific polymer solution for the preparation of a cross-linked hydrophilic coating.

Abstract: The invention concerns a device for detecting the presence of wind noise in an array of microphones comprising two or more separate sound inlet openings, and a sound to electrical converting element or microphone in relation to each sound inlet opening. The microphones generates each their time dependant signals, which are fed to a signal processing device, which provides one or more output signals. The signal processing device has means for generating a time dependant cross correlation function between a first and a second microphone signal and, means for generating a signal corresponding to a time dependant auto correlation function of either the first or the second of the microphone signals.

Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.

Abstract: A microfiltration process of a fermentation-derived product comprising adding activated carbon to a solution of the fermentation-derived product prior to or during the microfiltration process at a microfiltration process temperature of from 25° C. to 65° C.

Abstract: A microfiltration process of a fermentation-derived product comprising adding activated carbon to a solution of the fermentation-derived product prior to or during the microfiltration process at a microfiltration process temperature of from 25° C. to 65° C.